Article

A systematic comparison of pan-Trk immunohistochemistry assays across multiple cancer types

2022-09-02

Abstract excerpt

<title>Abstract</title> <p><italic>NTRK</italic>-rearranged tumors are rare but can be successfully treated using anti-TRK–targeted therapies making <italic>NTRK</italic> testing important for treatment choices in patients with advanced cancers. Pan-Trk immunohistochemistry (IHC) has become a valuable and affordable screening tool, but the choice of antibodies and IHC protocols to investigate biomarkers is not st...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2304b445-f754-54d9-8947-8605dbf2da27
DOI: 10.21203/rs.3.rs-1986852/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A systematic comparison of pan-Trk immunohistochemistry assays across multiple cancer typesDOI 10.21203/rs.3.rs-1986852/v1Read

Pan-TRK Immunohistochemistry: An Example-Based Practical Approach to Efficiently Identify Patients With NTRK Fusion Cancer.Semantic proximity Read

Immunohistochemistry as a screening tool for NTRK gene fusions: results of a first Belgian ring trial.Semantic proximity Read

NTRK Fusions, from the Diagnostic Algorithm to Innovative Treatment in the Era of Precision MedicineSemantic proximity Read

Integrated Evaluation of TRK Expression in Gastric Adenocarcinoma: Correlation with Immunohistochemistry- and In Situ Hybridization–Based Molecular Classification and Diagnostic ChallengesSemantic proximity Read

Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in AdultsSemantic proximity Read

Immunohistochemistry and Next-Generation Sequencing for NTRK Fusion detection in Differentiated Thyroid Cancer of Children, Adolescents and Young AdultsSemantic proximity Read

Testing algorithm for identification of patients with TRK fusion cancerSemantic proximity Read

Pan-TRK Immunohistochemistry Is Highly Correlated With NTRK3 Gene Rearrangements in Salivary Gland Tumors.Semantic proximity Read

Antitumor activity of larotrectinib in tumors harboring NTRK gene fusions: a short review on the current evidenceSemantic proximity Read

Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions.Semantic proximity Read

Multidisciplinary consensus on optimising the detection of NTRK gene alterations in tumoursSemantic proximity Read

Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in ChinaSemantic proximity Read